| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-18 | 2,500 | $3.07 | $7.68kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-15 | 3,400 | $2.68 | $9.11kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-12 | 5,000 | $3.12 | $15.60kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-09 | 2,343 | $3.15 | $7.38kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-29 | 800 | $2.74 | $2.19kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-28 | 9,200 | $2.86 | $26.34kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-21 | 3,508 | $2.79 | $9.80kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-20 | 15,000 | $1.53 | $22.95kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-20 | 2,000 | $2.72 | $5.44kBuy |
| Sudarshan Hebbar | Chief Medical Officer | 2025-08-19 | 9,563 | $2.82 | $26.96kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 33.43% | 5,281,713 | $4.49M | Insider |
| Orbimed Advisors LLC | 26.35% | 4,163,347 | $3.54M | Insider |
| Fred A. Middleton | 19.97% | 3,155,250 | $2.68M | Insider |
| Sanderling Venture Partners VI Co Investment Fund LP | 15.24% | 2,407,172 | $2.05M | Insider |
| Sanderling Venture Partners VI LP | 14.68% | 2,319,428 | $1.97M | Insider |
| Clarus Lifesciences III LP | 12.22% | 1,930,395 | $1.64M | Insider |
| Christy L. Shaffer | 10.17% | 1,606,669 | $1.37M | Insider |
| Hansoo Michael Keyoung | 7.18% | 1,133,596 | $963.56k | Insider |
| Eric W. Roberts | 6.73% | 1,063,737 | $904.18k | Insider |
| A. Rachel Leheny | 5.54% | 874,752 | $743.54k | Insider |